Healthleap Raises $38 Mn to Expand Clinical AI Screening for Undiagnosed Conditions

The startup plans to use the fresh funding to expand its screening capabilities to additional conditions and strengthen its workforce

San Francisco-based Clinical Artificial Intelligence platform Healthleap has raised $38 million in combined Seed and Series A financing backed by Sequoia Capital, First Round Capital, and Hummingbird Ventures

The startup plans to use the fresh funding to expand its screening capabilities to additional conditions and strengthen its workforce across engineering, sales, customer success, and product teams.

Founded in 2022 by sibling duo Josiah Meyer (CEO) and Jemima Meyer (clinician and co-founder), Healthleap operates as an EHR-integrated clinical surveillance layer initially focusing on disease-related malnutrition.

Its AI-based platform continuously analyzes every patient’s record, including notes, labs, vitals, orders, problem lists, and flags risk for conditions.

Further, it ranks patient risk and routes actionable scores into optimized EHR workflow to support clinicians in identifying, treating, and improving their patients’ health.

The approach is intended to help care teams prioritize patients whose conditions might otherwise go undetected during routine screening or develop after admission and who require evaluation first.

Commenting on the development, Josh Kopelman, First Round Capital co-founder and partner, said, “We were immediately drawn to Healthleap’s bold vision: imagine if every hospital could use real-time AI to spot overlooked clinical risk, improve patient care, and unlock meaningful reimbursement revenue. That’s exactly what Healthleap is delivering and more, starting with disease-related malnutrition and rapidly expanding across conditions to save lives and hospitals money.”

It also enables hospitals to screen their entire inpatient census daily with high diagnostic precision, identifying deteriorating or undernourished patients who would otherwise go unnoticed until post-discharge complications develop.

The startup further plans to expand its platform to address over 40 healthcare conditions, including congestive heart failure, pressure ulcers, and hospital-acquired infections, in addition to malnutrition.

According to the startup, its clinical intelligence platform has been deployed across 50 hospitals, including Penn Medicine, Houston Methodist, Cedars-Sinai, and Emory Healthcare.

Speaking on the new capital, Josiah Meyer, Healthleap's CEO, stated that the startup plans to use the fresh capital to expand "beyond malnutrition to more than 40 conditions," adding that targeted expansion areas include delirium, aspiration pneumonia, and pressure injuries.

"Our goal is to improve care and save lives by catching these conditions early,” Josiah said.

Stay tuned for more such updates on Digital Health News